Table 2 Univariate and multivariate analyses of factors predicting HR-HPV clearance
HR-HPV clearance | Multivariate analysis | ||||
|---|---|---|---|---|---|
Yes (n = 68) | No (n = 53) | p-value | HR (95% CI) | p-value | |
Age, years (mean ± SD) | 44.72 ± 10.50 | 45.00 ± 11.58 | 0.890 | 0.494 (0.092, 2.654) | 0.623 |
Post-menopause | 21 (30.9%) | 16 (30.2%) | 0.986 | 1.007 (0.451, 2.251) | 0.848 |
Parity | 1.81 ± 1.01 | 2.28 ± 1.25 | 0.030 | 2.100 (0.949, 4.648) | 0.105 |
IUD | 8 (11.8%) | 4 (7.6%) | 0.752 | 1.469 (0.405, 5.326) | 0.734 |
Educational level (College or above) | 25 (36.7%) | 14 (26.4%) | 0.310 | 1.637 (0.725, 3.693) | 0.440 |
Employed | 44 (64.7%) | 34 (64.1%) | 0.846 | 1.107 (0.513, 2.386) | 0.449 |
History of TH | 4 (5.9%) | 7 (13.2%) | 0.104 | 0.260 (0.065, 1.032) | 0.147 |
Probiotics used | 36 (52.9%) | 26 (49.1%) | 0.716 | 1.168 (0.569, 397) | 0.672 |
Viral load (RLU/PC) (mean ± SD) | 313.82 ± 616.28 | 561.88 ± 868.58 | 0.019 | 3.214 (1.398, 7.392) | 0.006 |